Highly Cited Article Collection of Neurodegenerative Diseases

This Highly Cited Article Collection showcases the leading research published in Neurodegenerative Diseases in the past 3 years, highlighting diverse aspects of neurodegeneration. Free to read through December 31, 2022.

Highly Cited Articles

•  
  The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline
  Pyne J.D. · Brickman A.M.
  Neurodegener Dis 2021;21:1–23 (DOI:10.1159/000518581)

   

•  
  Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson’s Disease and Atypical Parkinsonian Syndromes
  Kaiserova M. · Chudackova M. · Prikrylova Vranova H. · Mensikova K. · Kastelikova A. · Stejskal D. · Kanovsky P.
  Neurodegener Dis 2021;21:30–35 (DOI:10.1159/000520302)

   

•  
  Ferroptosis Is Regulated by Mitochondria in Neurodegenerative Diseases
  Zhou J. · Jin Y. · Lei Y. · Liu T. · Wan Z. · Meng H. · Wang H.
  Neurodegener Dis 2020;20:20–34 (DOI:10.1159/000510083)

   

•  
  First Recognized Patient with Genetic Vitamin E Deficiency Stable after 36 Years of Controlled Supplement Therapy
  Kohlschütter A. · Finckh B. · Nickel M. · Bley A. · Hübner C.
  Neurodegener Dis 2020;20:35–38 (DOI:10.1159/000508080)

   

•  
  Clinical Phenotype of LRRK2 R1441C in 2 Chinese Sisters
  Lim S.-Y. · Lim J.L. · Ahmad-Annuar A. · Lohmann K. · Tan A.H. · Lim K.B. · Tay Y.W. · Shing Y.L. · Muthusamy K.A. · Bauer P. · Rolfs A. · Klein C.
  Neurodegener Dis 2020;20:39–45 (DOI:10.1159/000508131)

   

•  
  Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson’s Disease
  He S. · Zhong S. · Liu G. · Yang J.
  Neurodegener Dis 2020;20:55–64 (DOI:10.1159/000511083)

   

•  
  Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson’s Disease
  Zhang M. · He Q. · Chen G. · Li P.A.
  Neurodegener Dis 2020;20:73–83 (DOI:10.1159/000511207)

   

•  
  Effects of Rivastigmine on Patients with Spinocerebellar Ataxia Type 3: A Case Series of Five Patients
  Grobe-Einsler M. · Vogt I.R. · Schaprian T. · Hurlemann R. · Klockgether T. · Kaut O.
  Neurodegener Dis 2020;20:104–109 (DOI:10.1159/000510057)

   

•  
  Prefrontal Cortex Transcriptomic Deconvolution Implicates Monocyte Infiltration in Parkinson’s Disease
  Batchu S.
  Neurodegener Dis 2020;20:110–112 (DOI:10.1159/000510218)

   

•  
  Postoperative Cognitive Dysfunction and the Protective Effects of Enriched Environment: A Systematic Review
  Hua M. · Min J.
  Neurodegener Dis 2020;20:113–122 (DOI:10.1159/000513196)

   

•  
  The Prevalence and Management of Saliva Problems in Motor Neuron Disease: A 4-Year Analysis of the Scottish Motor Neuron Disease Register
  Pearson I. · Glasmacher S.A. · Newton J. · Beswick E. · Mehta A.R. · Davenport R. · Chandran S. · Pal S. · CARE-MND consortium
  Neurodegener Dis 2020;20:147–152 (DOI:10.1159/000514615)

   

•  
  Diffusion Tensor Imaging Reveals Whole-Brain Microstructural Changes in the P301L Mouse Model of Tauopathy
  Massalimova A. · Ni R. · Nitsch R.M. · Reisert M. · von Elverfeldt D. · Klohs J.
  Neurodegener Dis 2020;20:173–184 (DOI:10.1159/000515754)

   

•  
  A Pilot Study of Urinary Exosomes in Alzheimer’s Disease
  Sun R. · Wang H. · Shi Y. · Gao D. · Sun Z. · Chen Z. · Jiang H. · Zhang J.
  Neurodegener Dis 2019;19:184–191 (DOI:10.1159/000505851)

   

•  
  CREB Protects against Temporal Lobe Epilepsy Associated with Cognitive Impairment by Controlling Oxidative Neuronal Damage
  Xing J. · Han D. · Xu D. · Li X. · Sun L.
  Neurodegener Dis 2019;19:225–237 (DOI:10.1159/000507023)

   

Connect with Us

Contact Us

If you have any questions, just get in touch with the Editorial Office